infohep news

• Coronavirus

  Coronavirus (COVID-19, SARS-CoV 2) and viral hepatitis: sources of information

  Keith Alcorn / 26 March 2020

  COVID-19 is a new illness that can affect your lungs and airways. It's caused by a virus called coronavirus. The most common symptoms of coronavirus are a fever (high temperature) and/or dry cough, shortness of ...

• Coronavirus

  Liver specialists offer guidance on COVID-19 risks in liver patients

  Keith Alcorn / 25 March 2020

  The American Association for the Study of Liver Diseases (AASLD) has issued preliminary guidance for liver specialists on managing COVID-19 in patients with liver disease, based on data published up to late March. COVID-19 ...

• NAFLD

  HIV-positive people with fatty liver disease are at high risk for fibrosis

  Liz Highleyman / 23 March 2020

  People living with HIV who have non-alcoholic fatty liver disease (NAFLD) often have liver fibrosis and are at risk for fibrosis worsening, researchers reported earlier this month at the Conference ...

• Hepatitis C elimination

  London sets out route map for hepatitis C elimination

  Keith Alcorn / 13 March 2020

  Healthcare professionals, local government and community organisations have launched a London route map for hepatitis C elimination, setting out five `opportunity` areas for an intensified focus on reaching undiagnosed people and vulnerable populations ...

• Screening and testing policy

  90% of people who inject drugs in United States missed opportunities for HIV or hepatitis C tests

  Keith Alcorn / 27 February 2020

  Around 90% of people who inject drugs in the United States missed opportunities for HIV or hepatitis C virus testing between 2010 and 2017, a review of more than 840,000 healthcare visits shows. ...